Search research articles
Contact Us
Filters
Showing results (1-10 of 182) with videos related to
Page
of 19
Sort By:
The Lancet. Oncology
|
June 15, 2016
Locally advanced pancreatic cancer: maybe not so local
Peter J O'Dwyer
Clinical Advances in Hematology & Oncology : H&O
|
February 13, 2015
The next generation of targeted therapy trials in colorectal cancer
Peter J O'Dwyer
Journal of the National Cancer Institute
|
September 1, 2022
Modified Eligibility Criteria: Patient Access and Subpopulation Applicability vs Efficiency in Drug Development
Peter J O'Dwyer
The Oncologist
|
October 13, 2006
The present and future of angiogenesis-directed treatments of colorectal cancer
Peter J O'Dwyer
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
July 16, 2003
Role of Jun and Jun kinase in resistance of cancer cells to therapy
Irina Vasilevskaya, Peter J O'Dwyer
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 1, 2022
Precision Medicine Clinical Trials: A Conversation Between Peter O'Dwyer and Lale Kostakoglu
Peter J O'Dwyer, Lale Kostakoglu
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2004
Monoclonal antibodies in the treatment of colorectal cancer
Maria Luisa Veronese, Peter J O'Dwyer
Seminars in Oncology
|
November 8, 2002
Epidermal growth factor receptor-targeted therapy in colorectal cancer
Peter J O'dwyer, Al B Benson
Biochemical Pharmacology
|
June 24, 2003
Role of the AP-1 element and redox factor-1 (Ref-1) in mediating transcriptional induction of DT-diaphorase gene expression by oltipraz: a target for chemoprevention
Kang-Shen Yao, Peter J O'Dwyer
The Journal of Biological Chemistry
|
March 30, 2004
NF-kappaB activation by the chemopreventive dithiolethione oltipraz is exerted through stimulation of MEKK3 signaling
Chu Won Nho, Peter J O'Dwyer
Page
of 19
Search research articles
Search
Showing results (1-10 of 182) with videos related to
Sort By:
Page
of 19
The Lancet. Oncology
|
June 15, 2016
Locally advanced pancreatic cancer: maybe not so local
Peter J O'Dwyer
Clinical Advances in Hematology & Oncology : H&O
|
February 13, 2015
The next generation of targeted therapy trials in colorectal cancer
Peter J O'Dwyer
Journal of the National Cancer Institute
|
September 1, 2022
Modified Eligibility Criteria: Patient Access and Subpopulation Applicability vs Efficiency in Drug Development
Peter J O'Dwyer
The Oncologist
|
October 13, 2006
The present and future of angiogenesis-directed treatments of colorectal cancer
Peter J O'Dwyer
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
July 16, 2003
Role of Jun and Jun kinase in resistance of cancer cells to therapy
Irina Vasilevskaya, Peter J O'Dwyer
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 1, 2022
Precision Medicine Clinical Trials: A Conversation Between Peter O'Dwyer and Lale Kostakoglu
Peter J O'Dwyer, Lale Kostakoglu
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2004
Monoclonal antibodies in the treatment of colorectal cancer
Maria Luisa Veronese, Peter J O'Dwyer
Seminars in Oncology
|
November 8, 2002
Epidermal growth factor receptor-targeted therapy in colorectal cancer
Peter J O'dwyer, Al B Benson
Biochemical Pharmacology
|
June 24, 2003
Role of the AP-1 element and redox factor-1 (Ref-1) in mediating transcriptional induction of DT-diaphorase gene expression by oltipraz: a target for chemoprevention
Kang-Shen Yao, Peter J O'Dwyer
The Journal of Biological Chemistry
|
March 30, 2004
NF-kappaB activation by the chemopreventive dithiolethione oltipraz is exerted through stimulation of MEKK3 signaling
Chu Won Nho, Peter J O'Dwyer
Page
of 19